首页 正文

Review Hepatology forum. 2024 Sep 10;6(1):29-33. doi: 10.14744/hf.2024.2024.0001 Q32.12025

Hepatopulmonary syndrome unveiled: Exploring pathogenesis, diagnostic approaches, and therapeutic strategies

肝肺综合征揭秘:探讨发病机制、诊断方法和治疗策略 翻译改进

Anusha Alam  1, Nazli Begum Ozturk  1, Filiz Akyuz  2

作者单位 +展开

作者单位

  • 1 Department of Internal Medicine, Beaumont Hospital, Michigan, United States.
  • 2 Department of Gastroenterology and Hepatology, Istanbul University School of Medicine, Istanbul, Turkiye.
  • DOI: 10.14744/hf.2024.2024.0001 PMID: 40255956

    摘要 中英对照阅读

    Hepatopulmonary syndrome (HPS) is a pulmonary complication of liver cirrhosis that causes an oxygenation defect. Many patients are asymptomatic at diagnosis or may have non-specific symptoms such as dyspnea. Since the diagnostic criteria for HPS have been established, its prevalence has been better estimated. HPS is an important prognostic indicator for patients undergoing evaluation for liver transplant. The implementation of the Model for End-stage Liver... ...点击完成人机验证后继续浏览

    肝肺综合征(HPS)是肝硬化的一种肺部并发症,会导致氧气缺陷。许多患者在诊断时无症状或可能出现呼吸困难等非特异性症状。自从建立了 HPS 的诊断标准以来,其发病率得到了更好的估计。对于正在接受肝脏移植评估的患者而言,HPS 是一个重要的预后指标。实施终末期肝病模型例外政策改善了 HPS 的结果;然而,死亡率仍然很高。在这里,我们讨论了 HPS 的发病机制、诊断标准以及最近的实验研究。

    关键词: 肝硬化;肝脏疾病;肝脏移植。

    翻译效果不满意? 用Ai改进或 寻求AI助手帮助 ,对摘要进行重点提炼
    Copyright © Hepatology forum. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Hepatology forum

    缩写:HEPATOL FORUM

    ISSN:1307-5888

    e-ISSN:2757-7392

    IF/分区:2.1/Q3

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Hepatopulmonary syndrome unveiled: Exploring pathogenesis, diagnostic approaches, and therapeutic strategies